These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12916916)

  • 1. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.
    Siewert M; Dressman J; Brown CK; Shah VP; ;
    AAPS PharmSciTech; 2003; 4(1):E7. PubMed ID: 12916916
    [No Abstract]   [Full Text] [Related]  

  • 2. [The history of dosage form from the German Pharmacopoeia I to II of East Germany].
    Heise HG; Heise J
    Pharmazie; 1984 Jul; 39(7):445-61. PubMed ID: 6494224
    [No Abstract]   [Full Text] [Related]  

  • 3. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].
    Stassen T; Piette M; Kinget R; Delattre L
    J Pharm Belg; 2006; 61(1):1-10. PubMed ID: 16669341
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic response in oral dosage forms.
    Morrison AB
    Med Serv J Can; 1967 Mar; 23(3):349-59. PubMed ID: 6056377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in the field of galenics (1965 to 1967)].
    Chalabala M; Malý J; Burelová A
    Pharmazie; 1969 Feb; 24(2):65-86. PubMed ID: 4891843
    [No Abstract]   [Full Text] [Related]  

  • 10. Basics of compounding: Tips and hints: powders, capsules, tablets, suppositories, and sticks, part 1.
    Allen LV
    Int J Pharm Compd; 2014; 18(1):42-5. PubMed ID: 24881340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Nov; 17(9):450-61. PubMed ID: 4888356
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethionamide blood levels after administration of the drug under various pharmaceutical forms.
    Verbist L; Dutoit M
    Arzneimittelforschung; 1966 Jun; 16(6):773-8. PubMed ID: 6014592
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro kinetics of drug release from oral dosage forms, lyophilized and conventional rectal suppositories.
    Bhavnagri VP; Speiser P
    Pharm Acta Helv; 1976; 51(1):10-8. PubMed ID: 951423
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.
    Möller H; Wirbitzki E
    Boll Chim Farm; 1993 Apr; 132(4):105-15. PubMed ID: 8333916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various galenic forms of the V Belgian Pharmacopoeia. V. Gelatin-coated pills, tablets, unguents, syrups, suppositories].
    Jaminet F
    Farmaco Prat; 1969 Oct; 24(10):593-641. PubMed ID: 5361891
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on AAPS Workshop: dissolution testing for the twenty-first century: linking critical quality attributes and critical process parameters to clinically relevant dissolution.
    Tong C; D'Souza SS; Parker JE; Mirza T
    Pharm Res; 2007 Sep; 24(9):1603-7. PubMed ID: 17385013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EFFECT OF DOSAGE FORMS ON THE ABSORPTION OF DRUGS].
    FINHOLT P
    Sven Farm Tidskr; 1964 Apr; 58():311-7 CONTD. PubMed ID: 14147392
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral dosage form design and its influence on dissolution rates for a series of drugs.
    Hom FS; Miskel JJ
    J Pharm Sci; 1970 Jun; 59(6):827-30. PubMed ID: 4192950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in drug technology in the years 1968 and 1969].
    Chalabala M; Malý J; Burelová A
    Cesk Farm; 1970 Nov; 19(9):332-60. PubMed ID: 4926371
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical sciences--1970: literature review of pharmaceutics.
    Benney TL; Hamlin WE
    J Pharm Sci; 1971 Jul; 60(7):959-1014. PubMed ID: 4940085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.